These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34398163)

  • 1. Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method.
    Luo X; Hu Y; Wang R; Zhang M; Zhong X; Zhang B
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34398163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregenual or subgenual anterior cingulate cortex as potential effective region for brain stimulation of depression.
    Jing Y; Zhao N; Deng XP; Feng ZJ; Huang GF; Meng M; Zang YF; Wang J
    Brain Behav; 2020 Apr; 10(4):e01591. PubMed ID: 32147973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression.
    Taylor SF; Ho SS; Abagis T; Angstadt M; Maixner DF; Welsh RC; Hernandez-Garcia L
    J Affect Disord; 2018 May; 232():143-151. PubMed ID: 29494898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional connectivity of the anterior cingulate cortex predicts treatment outcome for rTMS in treatment-resistant depression at 3-month follow-up.
    Ge R; Downar J; Blumberger DM; Daskalakis ZJ; Vila-Rodriguez F
    Brain Stimul; 2020; 13(1):206-214. PubMed ID: 31668646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression core network-based individualized targeting for transcranial magnetic stimulation.
    Raij TT; Komulainen E; Aydogan DB; Pamilo S; Isometsä E; Raij T
    Brain Stimul; 2023; 16(2):619-627. PubMed ID: 36931462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites.
    Weigand A; Horn A; Caballero R; Cooke D; Stern AP; Taylor SF; Press D; Pascual-Leone A; Fox MD
    Biol Psychiatry; 2018 Jul; 84(1):28-37. PubMed ID: 29274805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel concurrent TMS-fMRI method to reveal propagation patterns of prefrontal magnetic brain stimulation.
    Vink JJT; Mandija S; Petrov PI; van den Berg CAT; Sommer IEC; Neggers SFW
    Hum Brain Mapp; 2018 Nov; 39(11):4580-4592. PubMed ID: 30156743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subgenual cingulate connectivity as a treatment predictor during low-frequency right dorsolateral prefrontal rTMS: A concurrent TMS-fMRI study.
    Tan V; Jeyachandra J; Ge R; Dickie EW; Gregory E; Vanderwal T; Vila-Rodriguez F; Hawco C
    Brain Stimul; 2023; 16(4):1165-1172. PubMed ID: 37543171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of repetitive transcranial magnetic stimulation on individual variability of resting-state functional connectivity in major depressive disorder.
    Tan V; Downar J; Nestor S; Vila-Rodriguez F; Daskalakis ZJ; Blumberger DM; Hawco C
    J Psychiatry Neurosci; 2024; 49(3):E172-E181. PubMed ID: 38729664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Task-related functional magnetic resonance imaging-based neuronavigation for the treatment of depression by individualized repetitive transcranial magnetic stimulation of the visual cortex.
    Zhang Z; Zhang H; Xie CM; Zhang M; Shi Y; Song R; Lu X; Zhang H; Li K; Wang B; Yang Y; Li X; Zhu J; Zhao Y; Yuan TF; Northoff G
    Sci China Life Sci; 2021 Jan; 64(1):96-106. PubMed ID: 32542515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subgenual Anterior Cingulate-Medial Orbitofrontal Functional Connectivity in Medication-Resistant Major Depression: A Neurobiological Marker for Accelerated Intermittent Theta Burst Stimulation Treatment?
    Baeken C; Duprat R; Wu GR; De Raedt R; van Heeringen K
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Oct; 2(7):556-565. PubMed ID: 29560909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the dorsolateral prefrontal cortex targeting approaches for transcranial magnetic stimulation treatment: Insights from the healthy control data.
    Kinjo M; Honda S; Wada M; Nakajima S; Koike S; Noda Y
    Brain Res; 2024 Sep; 1838():148989. PubMed ID: 38723740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Accelerated HF-rTMS on the Subgenual Anterior Cingulate Cortex in Refractory Unipolar Major Depression: Insights From 18FDG PET Brain Imaging.
    Baeken C; Marinazzo D; Everaert H; Wu GR; Van Hove C; Audenaert K; Goethals I; De Vos F; Peremans K; De Raedt R
    Brain Stimul; 2015; 8(4):808-15. PubMed ID: 25744500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized prediction of transcranial magnetic stimulation clinical response in patients with treatment-refractory depression using neuroimaging biomarkers and machine learning.
    Hopman HJ; Chan SMS; Chu WCW; Lu H; Tse CY; Chau SWH; Lam LCW; Mak ADP; Neggers SFW
    J Affect Disord; 2021 Jul; 290():261-271. PubMed ID: 34010751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated HF-rTMS in treatment-resistant unipolar depression: Insights from subgenual anterior cingulate functional connectivity.
    Baeken C; Marinazzo D; Wu GR; Van Schuerbeek P; De Mey J; Marchetti I; Vanderhasselt MA; Remue J; Luypaert R; De Raedt R
    World J Biol Psychiatry; 2014 May; 15(4):286-97. PubMed ID: 24447053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical and fMRI-network comparison of multiple DLPFC targeting strategies for repetitive transcranial magnetic stimulation treatment of depression.
    Cardenas VA; Bhat JV; Horwege AM; Ehrlich TJ; Lavacot J; Mathalon DH; Glover GH; Roach BJ; Badran BW; Forman SD; George MS; Thase ME; Yesavage JA; Yurgelun-Todd D; Rosen AC
    Brain Stimul; 2022; 15(1):63-72. PubMed ID: 34767967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision targeting in prediction for rTMS clinical outcome in depression: what about sgACC lateralization, metabolic connectivity, and the potential role of the cerebellum?
    Wu GR; Baeken C
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1443-1450. PubMed ID: 37329365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression.
    Williams LM; Coman JT; Stetz PC; Walker NC; Kozel FA; George MS; Yoon J; Hack LM; Madore MR; Lim KO; Philip NS; Holtzheimer PE
    BMC Psychiatry; 2021 Jan; 21(1):35. PubMed ID: 33435926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional connectivity analysis of the depression connectome provides potential markers and targets for transcranial magnetic stimulation.
    Taylor H; Nicholas P; Hoy K; Bailey N; Tanglay O; Young IM; Dobbin L; Doyen S; Sughrue ME; Fitzgerald PB
    J Affect Disord; 2023 May; 329():539-547. PubMed ID: 36841298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Changes in Depressive Circuitry in Response to Neuromodulation Therapy.
    Pathak Y; Salami O; Baillet S; Li Z; Butson CR
    Front Neural Circuits; 2016; 10():50. PubMed ID: 27524960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.